Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Symbiomix Therapeutics accelerates commercial launch for Solosec

Aug. 18, 2016

Study adds to complexity of nasal flu vaccine picture

Aug. 17, 2016

Japan Tobacco seeks Japanese approval for emtricitabine/tenofovir alafenamide

Aug. 17, 2016

Eiger initiates phase II trial of pegylated interferon lambda for chronic HDV infection

Aug. 17, 2016

Trek Therapeutics in-licenses rights to Medivir's MIV-802

Aug. 17, 2016

Sanofi announces public dengue immunization program in Brazil with Dengvaxia

Aug. 16, 2016

Novadigm Therapeutics discloses positive data from phase IIa trial

Aug. 16, 2016

Novel DNA vaccines provide enhanced protection from Pseudomonas aeruginosa in mice

Aug. 16, 2016

Wockhardt reports beta-lactamase inhibitors

Aug. 12, 2016

Targeting the parasite proteosome shows promise for the treatment of kinetoplastid infections

Aug. 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...